Evidence map›Paper›PMID 35280496›Full record

ArticleAfrican journal of urology : the official journal of the Pan African Urological Surgeons' Association (PAUSA)2022

A comparison of clinicopathologic features of prostate cancer between Nigerian and South African black men.

Ridwan Oladotun Ahmed, Vikash Sewram, Adisa Rasaaq Oyesegun, Birhanu Ayele, Abrie van Wyk, Pedro Fernandez

Abstract read
In one paragraph

Article in African journal of urology : the official journal of the Pan African Urological Surgeons' Association (PAUSA), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Prostate cancer in Nigeria: a scoping review and meta-analysis of current evidence on process indicators and interventions.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology · 2025
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The profile of Black South African men diagnosed with prostate cancer in the Free State, South Africa.South African family practice : official journal of the South African Academy of Family Practice/Primary Care · 2023
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ridwan Oladotun AhmedAfrican Cancer Institute, Department of Global Health, Stellenbosch University, PO Box 241, Tygerberg, 8000 South Africa.ORCID 0000-0002-8152-5129
Vikash SewramAfrican Cancer Institute, Department of Global Health, Stellenbosch University, PO Box 241, Tygerberg, 8000 South Africa.
Adisa Rasaaq OyesegunDepartment of Radiotherapy and Oncology, National Hospital, Plot 132, Central District (Phase II), P.M.B 425, Garki, Abuja, Nigeria.
Birhanu AyeleAfrican Cancer Institute, Department of Global Health, Stellenbosch University, PO Box 241, Tygerberg, 8000 South Africa.
Abrie van WykDivision of Anatomical Pathology, Department of Pathology, Stellenbosch University, PO Box 241, Cape Town, 8000 South Africa.
Pedro FernandezDivision of Urology, Department of Surgical Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000 South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Globally, prostate cancer (PCa) is the commonest non-cutaneous male malignancy. It is more aggressive among black men with little known reasons as to the cause and continued trend among black men. This disproportionate pattern of PCa especially among black men of African ancestry resident in Africa calls for a closer look. Nigeria and South Africa, combined, have the highest cumulative risk incidence of PCa in Africa. The present study investigated the clinicopathologic behaviour of PCa among Nigerian and South African black men and the relationship between the disease and socio-demographic characteristics alongside medical co-morbidities. Methods: A retrospective cross-sectional study was undertaken in which de-identified records of 234 black men with pathologically confirmed PCa between 2007 and 2017 from two tertiary hospitals, in Nigeria (National Hospital, Abuja) and South Africa (Tygerberg Hospital, Cape Town), were reviewed. Results: Median age at presentation from both countries was 66 years (interquartile range, IQR 61-73 years) while the median PSA at presentation was 46 ng/ml (IQR 16-336.5 ng/ml). Half of the men (117/234) presented with locally advanced disease while metastatic disease was observed in 65.9% (27/41) of Nigerian men and 34.1% (14/41) of South African men. Thirty-three per cent of the men presented with organ-confined disease. Overall, Nigerian men presented with less organ-confined disease and significantly higher stage of disease ( Conclusions: Disparities exist between PCa presentation and clinicopathologic behaviour among Nigerian and South African black men. Nigerian men showed higher disease risk at presentation. Environmental-genetic interactions need further exploration in the aetio-pathogenesis of PCa in black men of African ancestry.

Indexed as

African ancestryAgeBlack menGleason scoreProstate cancerPSARisk factors

Identifiers

PMID35280496
PMCPMC8897758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.